- ADVERTISEMENT
-
Most Popular
- ADVERTISEMENT
Stocks to Buy
Ocugen Should Hit $9 If Its Covid-19 Vaccine Gets Approved
Ocugen still hopes its Covid-19 vaccine gets approved to start making revenue. OCGN-stock could be worth as much as $9.09 or 19% over today's price assuming its Covid-19 vaccine gets approval.
Value, Dividends and Top-Tier Tech Make Oracle an Easy Choice
Is ORCL stock expensive? The share price has certainly moved higher, yet there are multiple reasons to view the stock as a terrific bargain.
The Unheard-Of Cryptocurrency That Will Replace Verizon
The time to buy the dip in cryptos is now; you should consider taking a position in Helium (HNT-USD) today.
A So-Called “Meme Stock” That’s Actually Worth the Hype
Not all meme stocks are fundamentally broken, you should consider taking a position in Clover (CLOV) today.
It’s Time to Get Bullish on Bitcoin Miners…
If you’re looking for a nice asymmetric bet on rebounding bitcoin prices, you should consider taking a position in Bit Digital (BTBT) today.
A Freshly Public Stock for the Burgeoning “Video Economy”
Vimeo (VMEO) is an all-in-one video software solution that helps companies and individuals create, collaborate and communicate with video.
An Explosive Stock Pick Hiding “Underneath” the Electric Vehicle Revolution
Exro Technologies (EXROF)'s tech can optimize EVs for both torque and speed without adding that much more weight or costs into the system.
This is the Best Turnaround Story in E-Commerce Today
Wish.com is now a publicly listed company under the name ContextLogic (WISH) that has more than 100 million monthly active users.
As the Resale Market Booms, This Brand-New Hypergrowth E-Retail Stock Will Soar
ThredUp (NASDAQ:TDUP) has created the world’s largest mass-market used apparel e-retail marketplace. It’s a win-win, two-sided marketplace.